CAS No.133-92-6,KANAMYCIN SULFATE Suppliers

Products Categories

Pharmaceutical (26)
Organic Chemicals (5)
Others (2)

Basic Information

Molecular Structure:
CAS No.:	133-92-6
Name:	KANAMYCIN SULFATE
Article Data:	2

Formula:	C₁₈H₃₈N₄O₁₅S
Molecular Weight:	582.584
Synonyms:	KANAMYCIN A;KANAMYCIN SULPHATE;KANAMYCIN SULFATE WHITE;KANAMYCIN SULFATE, STREPTOMYCES KANAMYCETICUS;KANAMYCIN SULFATE SALT;KANAMYCIN MONOSULFATE;KANAMYCIN MONO SULPHATE;KANAMYCIN MONOSULFATE SALT
Boiling Point:	809.5 °C at 760 mmHg
Flash Point:	443.4 °C
Safety:	22-24/25
PSA:	365.59000
LogP:	-4.06220

Country:
- China (Mainland)(32)
- United States(1)
Business Type:
All

Lab/Research institutions

Trading Company

Manufacturers

Other
Certificate:
Manufacturer

Enterprise Authentication

ISO

GMP

FDA

HALAL

Display:default sort
Suppiers of more reward points first

New supplier

Total:33 Page 1 of 1 1

Post a RFQ

Cas No.:

Product Name:

Quantity:

Email:

Company name:

Valid Period:

Detailed Requirements:

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

What can I do for you?
Get Best Price

Get Best Price for 133-92-6

Specification

The Kanamycin acid Sulfate is an organic compound with the formula C₁₈H₃₈N₄O₁₅S. The IUPAC name of this chemical is 2-(aminomethyl)-6-[4,6-diamino-3-[4-amino-3,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-2-hydroxycyclohexyl]oxyoxane-3,4,5-triol; sulfuric acid. With the CAS registry number 133-92-6, it is also named as (1S,2R,3R,4S,6R)-4,6-Diamino-3-[(6-amino-6-deoxy-α-D-glucopyranosyl)oxy]-2-hydroxycyclohexyl 3-amino-3-deoxy-α-D-glucopyranoside sulfate (1:1). The product's category is Antibiotics.

Physical properties about Kanamycin acid Sulfate are: (1)ACD/LogP: -2.58; (2)# of Rule of 5 Violations: 2; (3)#H bond acceptors: 15 #H bond donors: 15; (4)#Freely Rotating Bonds: 17; (5)Polar Surface Area: 114.49 Å²; (6)Flash Point: 443.4 °C; (7)Enthalpy of Vaporization: 134 kJ/mol; (8)Boiling Point: 809.5 °C at 760 mmHg; (9)Vapour Pressure: 2.47E-30 mmHg at 25°C.

You can still convert the following datas into molecular structure:
(1)SMILES: O=S(=O)(O)O.O([C@@H]2[C@@H](O)[C@H](O[C@H]1O[C@H](CN)[C@@H](O)[C@H](O)[C@H]1O)[C@@H](N)C[C@H]2N)[C@H]3O[C@@H]([C@@H](O)[C@H](N)[C@H]3O)CO
(2)InChI: InChI=1/C18H36N4O11.H2O4S/c19-2-6-10(25)12(27)13(28)18(30-6)33-16-5(21)1-4(20)15(14(16)29)32-17-11(26)8(22)9(24)7(3-23)31-17;1-5(2,3)4/h4-18,23-29H,1-3,19-22H2;(H2,1,2,3,4)/t4-,5+,6-,7-,8+,9-,10-,11-,12+,13-,14-,15+,16-,17-,18-;/m1./s1
(3)InChIKey: OOYGSFOGFJDDHP-KMCOLRRFBH
(4)Std. InChI: InChI=1S/C18H36N4O11.H2O4S/c19-2-6-10(25)12(27)13(28)18(30-6)33-16-5(21)1-4(20)15(14(16)29)32-17-11(26)8(22)9(24)7(3-23)31-17;1-5(2,3)4/h4-18,23-29H,1-3,19-22H2;(H2,1,2,3,4)/t4-,5+,6-,7-,8+,9-,10-,11-,12+,13-,14-,15+,16-,17-,18-;/m1./s1
(5)Std. InChIKey: OOYGSFOGFJDDHP-KMCOLRRFSA-N

The toxicity data is as follows:

Organism	Test Type	Route	Reported Dose (Normalized Dose)	Effect	Source
child	TDLo	intramuscular	390mg/kg (390mg/kg)	SENSE ORGANS AND SPECIAL SENSES: CHANGE IN ACUITY: EAR	Journal of Pediatrics. Vol. 60, Pg. 230, 1962.
mouse	LD50	intramuscular	1190mg/kg (1190mg/kg)		Drugs in Japan Vol. 6, Pg. 173, 1982.
mouse	LD50	intraperitoneal	1353mg/kg (1353mg/kg)		Antimicrobial Agents and Chemotherapy Vol. -, Pg. 138, 1963.
mouse	LD50	intravenous	240mg/kg (240mg/kg)		Drugs in Japan Vol. 6, Pg. 173, 1982.
mouse	LD50	oral	17500mg/kg (17500mg/kg)		Drugs in Japan Vol. 6, Pg. 173, 1982.
mouse	LD50	subcutaneous	1100mg/kg (1100mg/kg)	BEHAVIORAL: CHANGES IN MOTOR ACTIVITY (SPECIFIC ASSAY) LUNGS, THORAX, OR RESPIRATION: OTHER CHANGES	Antibiotiki. Vol. 29, Pg. 851, 1984.
rabbit	LD50	intramuscular	> 3gm/kg (3000mg/kg)		Japanese Journal of Antibiotics. Vol. 28, Pg. 415, 1975.
rabbit	LD50	intravenous	550mg/kg (550mg/kg)		Japanese Journal of Antibiotics. Vol. 28, Pg. 415, 1975.
rabbit	LD50	oral	> 3gm/kg (3000mg/kg)		Japanese Journal of Antibiotics. Vol. 28, Pg. 415, 1975.
rabbit	LD50	subcutaneous	> 3gm/kg (3000mg/kg)		Japanese Journal of Antibiotics. Vol. 28, Pg. 415, 1975.
rat	LD50	intramuscular	> 4gm/kg (4000mg/kg)		Japanese Journal of Antibiotics. Vol. 28, Pg. 415, 1975.
rat	LD50	intraperitoneal	3200mg/kg (3200mg/kg)		Japanese Journal of Antibiotics. Vol. 28, Pg. 415, 1975.
rat	LD50	intravenous	225mg/kg (225mg/kg)		Japanese Journal of Antibiotics. Vol. 28, Pg. 415, 1975.
rat	LD50	oral	> 4gm/kg (4000mg/kg)		Japanese Journal of Antibiotics. Vol. 28, Pg. 415, 1975.
rat	LD50	subcutaneous	1700mg/kg (1700mg/kg)		Arzneimittel-Forschung. Drug Research. Vol. 12, Pg. 597, 1962.